Homecare brand Beco has launched a campaign, #WarOnWhatsHidden, directly comparing its laundry and dishwashing products with Hindustan Unilever Ltd's (HUL) Surf Excel and Vim. Beco claims independent tests detected ingredients like benzisothiazolinone…
Hindustan Unilever on Friday won a Rs 29,000 crore tax dispute at the Bombay High Court, which ruled that a tax notice issued in 2021 for the 2018-19 assessment year was time-barred…
The Delhi High Court on Monday reserved its order on whether it can hear Hindustan Unilever's plea against Beco over an advertising campaign that HUL alleges falsely portrays its Surf Excel and…
India's fast-moving consumer goods (FMCG) sector has seen an unusually intense wave of leadership turnover over the past year, with at least half a dozen top companies replacing chief executives or reshaping…
Four of India's 10 most valued companies lost a combined Rs 87,960.29 crore in market capitalisation last week as bearish equity markets dragged down heavyweight shares. Bharti Airtel suffered the biggest erosion,…
Indian companies across consumer goods, automobiles, tyres and paints have either raised prices or signalled increases as higher commodity, packaging, freight and energy costs squeeze margins. Tata Consumer Products has hiked salt…
Roshni Nadar Malhotra, chairperson of HCLTech, has been named the top Wealth Multiplier in the 2026 Candere Hurun India Women Leaders List released on Thursday. Hindustan Unilever CEO Priya Nair leads the…
Television advertising volumes in India declined 7% in the January-July 2026 period compared with a year earlier, according to ad market tracker TAM AdEx. This follows a 9% drop in ad volumes…
India’s consumption landscape is pivoting from volume-led growth to value-led expansion, with affluent households spending more on premium FMCG brands, luxury housing, financial products, travel and discretionary categories. Investors are now scanning…
Indian companies are racing to launch protein-rich foods, collagen supplements and face fillers to capitalise on side effects from the growing use of GLP-1 weight-loss drugs such as Ozempic and Mounjaro.
